Yuri Kukushkin

Yury Kukushkin is a biotech professional with extensive experience in the life sciences and investment sectors. Here are some key details about his background and career:

Professional Experience

Current Role: Yury Kukushkin currently serves as the Managing Director at JDRF T1D Fund.1 He is also associated with Hevolution Foundation.2

Co-Founder of Future Biotech: Kukushkin co-founded Future Biotech, a company focused on promoting sustainable biotechnology solutions. He held this role from May 2012 to June 2017.4

Previous Positions:

• Principal and later Venture Partner at 4BIO Capital, a London-based fund investing in public and private life sciences companies1
• Chief Analyst and Associate at RBV Capital, an early-stage life sciences venture fund14

Education

Yury Kukushkin has a strong academic background in biochemistry and cellular biology:

• M.S. in Biochemistry with specialization in Virology from Moscow State University1
• Ph.D. in Cellular Biochemistry from Max Planck Institute of Biochemistry, Martinsried, Germany1

Personal Insight

As a biotech professional and someone living with Type 1 diabetes, Kukushkin has expressed optimism about advancements in treating the disease, particularly noting the FDA approval of TZIELD™ (teplizumab-mzwv) for future generations affected by diabetes.3

Yury Kukushkin's diverse experience in biotechnology, venture capital, and his personal connection to medical research make him a notable figure in the biotech industry.